Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trial

Neurology
Evan J H LewisV Bril

Abstract

To test the hypothesis that 12 months of seal oil omega-3 polyunsaturated fatty acids (ω-3 PUFA) supplementation will stop the known progression of diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes mellitus (T1DM). Individuals with T1DM and evidence of DSP as determined by a Toronto Clinical Neuropathy Score ≥1 were recruited to participate in a single-arm, open-label trial of seal oil ω-3 PUFA supplementation (10 mL·d-1; 750 mg eicosapentaenoic acid, 560 mg docosapentaenoic acid, and 1,020 mg docosahexaenoic acid) for 1 year. The primary outcome was the 1-year change in corneal nerve fiber length (CNFL) measured by in vivo corneal confocal microscopy, with sensory and nerve conduction measures as secondary outcomes. Forty participants (53% female), aged 48 ± 14 years, body mass index 28.1 ± 5.8 with diabetes duration of 27 ± 18 years, were enrolled. At baseline, 23 participants had clinical DSP and 17 did not. Baseline CNFL was 8.3 ± 2.9 mm/mm2 and increased 29% to 10.1 ± 3.7 mm/mm2 (p = 0.002) after 12 months of supplementation. There was no change in nerve conduction or sensory function. Twelve months of ω-3 supplementation was associated with increase in CNFL in T1DM. NCT02034266. This study provides Class IV ev...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Feb 1, 1997·Muscle & Nerve·D Yarnitsky
Oct 29, 2002·Diabetes Care·Vera Bril, Bruce A Perkins
Mar 29, 2005·Diabetes Care·Andrew J M BoultonUNKNOWN American Diabetes Association
Mar 26, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·V BrilUNKNOWN mTCNS Study Group
Nov 13, 2009·Investigative Ophthalmology & Visual Science·Peter YeeAlgis J Vingrys
Feb 13, 2010·Diabetes Care·James W AlbersUNKNOWN Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group
Feb 24, 2012·Diabetes Care·Steven OrlovBruce A Perkins
Apr 24, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·T WuB A Perkins
May 11, 2012·Journal of the Peripheral Nervous System : JPNS·Vera Bril
May 23, 2012·Lancet Neurology·Brian C CallaghanEva L Feldman
Jun 13, 2012·The New England Journal of Medicine·Jackie BoschSalim Yusuf
May 25, 2013·Investigative Ophthalmology & Visual Science·Maria Soledad CortinaHaydee E P Bazan
Feb 27, 2014·Investigative Ophthalmology & Visual Science·Ioannis N PetropoulosRayaz A Malik
Jun 4, 2014·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·N BenderM Egger
Nov 13, 2014·Nature Reviews. Neuroscience·Richard P Bazinet, Sophie Layé
Sep 18, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zhuo-Hao LiuAdina T Michael-Titus
Feb 18, 2016·Diabetes Care·John WahrenJoseph C Arezzo

❮ Previous
Next ❯

Citations

Sep 28, 2018·Diabetes/metabolism Research and Reviews·Ernesto Maddaloni
Oct 9, 2018·Annals of Neurology·Odelya E PagovichRonald G Crystal
Jul 25, 2019·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Isabel ConceiçãoAntoine Rousseau
Jan 13, 2018·Toxicological Sciences : an Official Journal of the Society of Toxicology·Samantha J SnowUrmila P Kodavanti
May 13, 2020·Journal of the Peripheral Nervous System : JPNS·Rayaz A Malik, Nigel A Calcutt
Oct 3, 2017·Neural Regeneration Research·Marta Sacchetti, Alessandro Lambiase
Jun 15, 2019·Nature Reviews. Disease Primers·Eva L FeldmanVijay Viswanathan
Aug 8, 2019·The Journal of Clinical Endocrinology and Metabolism·Sonja PüttgenDan Ziegler
Mar 6, 2019·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Ioannis N PetropoulosRayaz A Malik
Aug 27, 2018·Current Diabetes Reports·Mark A Yorek
May 12, 2019·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Lindsay A Zilliox, James W Russell
Jun 4, 2020·Journal of Diabetes Investigation·Hoda GadRayaz A Malik
Sep 17, 2020·Translational Vision Science & Technology·Ioannis N PetropoulosRayaz A Malik
Aug 24, 2018·Diabetes & Metabolism Journal·Ioannis N PetropoulosRayaz A Malik
Jan 22, 2021·Investigative Ophthalmology & Visual Science·Zohaib IqbalHandrean Soran
Mar 9, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Tushar IssarArun V Krishnan
Apr 17, 2021·Clinics in Geriatric Medicine·Lindsay A Zilliox
May 10, 2021·Clinical Therapeutics·Ioannis N PetropoulosRayaz A Malik
Jun 15, 2021·Frontiers in Endocrinology·Josie CarmichaelMitra Tavakoli
Aug 20, 2021·Metabolism: Clinical and Experimental·Simona Cernea, Itamar Raz
Aug 28, 2021·Current Diabetes Reports·Tina Okdahl, Christina Brock
Nov 6, 2021·Scientific Reports·Ioannis N PetropoulosRayaz A Malik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.